Search

Author/Creator Shi, Fengxia

1. Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferers. (April 2015)

Authors:
Zhang, Yajing; Xia, Lei; Zhang, Yan; Wang, Yao; Lu, Xuechun; Shi, Fengxia; Liu, Yang; Chen, Meixia; Feng, Kaixhao; Zhang, Wenying; Fu, Xiaobing; Han, Weidong
Journal:
Expert opinion on biological therapy
Issue:
Volume 15:Number 4(2015:Apr.)
Page Start:
481
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferers. (April 2015)

Authors:
Zhang, Yajing; Xia, Lei; Zhang, Yan; Wang, Yao; Lu, Xuechun; Shi, Fengxia; Liu, Yang; Chen, Meixia; Feng, Kaixhao; Zhang, Wenying; Fu, Xiaobing; Han, Weidong
Journal:
Expert opinion on biological therapy
Issue:
Volume 15:Number 4(2015:Apr.)
Page Start:
481
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early. Issue 7 (25th April 2020)

Authors:
Tan, Chaochao; Huang, Ying; Shi, Fengxia; Tan, Kui; Ma, Qionghui; Chen, Yong; Jiang, Xixin; Li, Xiaosong
Other Names:
Luo Guangxiang (George) guestEditor.; Gao Shou‐Jiang guestEditor.
Journal:
Journal of medical virology
Issue:
Volume 92:Issue 7(2020)
Page Start:
856
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma. Issue 4 (5th April 2021)

Authors:
Liu, Yang; Wang, Chunmeng; Li, Xiang; Dong, Liang; Yang, Qingming; Chen, Meixia; Shi, Fengxia; Brock, Malcolm; Liu, Miao; Mei, Qian; Liu, Jiejie; Nie, Jing; Han, Weidong
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 4(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report. (20th May 2014)

Authors:
Fan, Hui; Lu, Xuechun; Wang, Xiaohui; Liu, Yang; Guo, Bo; Zhang, Yan; Zhang, Wenying; Nie, Jing; Feng, Kaichao; Chen, Meixia; Zhang, Yajing; Wang, Yao; Shi, Fengxia; Fu, Xiaobing; Zhu, Hongli; Han, Weidong
Other Names:
Koido Shigeo Academic Editor.
Journal:
Journal of immunology research
Issue:
Volume 2014(2014)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗